Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1994-8-2
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0007-5248
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5-8
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:1670292-Arthritis, Rheumatoid,
pubmed-meshheading:1670292-Endothelium,
pubmed-meshheading:1670292-Fibroblasts,
pubmed-meshheading:1670292-Folic Acid,
pubmed-meshheading:1670292-Humans,
pubmed-meshheading:1670292-Immunosuppression,
pubmed-meshheading:1670292-Inflammation,
pubmed-meshheading:1670292-Methotrexate
|
pubmed:year |
1991
|
pubmed:articleTitle |
Mechanisms of action of methotrexate.
|
pubmed:affiliation |
Division of Rheumatology, Vanderbilt University School of Medicine, Nashville, TN.
|
pubmed:publicationType |
Journal Article,
Review
|